Answers are grounded in this paper and cite their sources.
An editorial discussing the efficacy and potential tolerance development associated with nitroglycerin patches in the management of angina pectoris.
Editorials1 April 1985Efficacy of Nitroglycerin Patches: Fact or Fancy?JOHN O. PARKER, M.D.JOHN O. PARKER, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-102-4-548 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe organic nitrates have been the most commonly used agents in the management of patients with angina pectoris. Although various beta-adrenoreceptor blocking agents and calcium-entry blocking drugs are now available, the nitrates remain important in the prophylaxis of angina and are the drugs of choice in the treatment of spontaneous or exercise-induced angina pectoris. When administered orally, the organic nitrates are considered to provide protection for periods of several hours and are usually taken four times daily. Recent studies, however, have shown the development of tolerance to the antianginal effects of the orally administered organic nitrates (1-3). The initial administration...References1. THADANIFUNGDARKEPARKER UHAJ. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol. 1982;49:411-9. CrossrefMedlineGoogle Scholar2. DALALYAOPARKER JLJ. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol. 1983;2:115-20. CrossrefMedlineGoogle Scholar3. PARKERFUNG JH. Nitrate tolerance—a comparison of buccal nitroglycerin and oral isosorbide dinitrate [Abstract]. Circulation. 1984;70(4 pt 2): II-189. Google Scholar4. REICHEKGOLDSTEINREDWOODEPSTEIN NRDS. Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation. 1974;50:348-52. CrossrefMedlineGoogle Scholar5. COLFERSTETSONLUCCHESIWAGNERPITT HPBJB. The nitroglycerin polymer gel matrix system: a new method for administering nitroglycerin evaluated with plasma nitroglycerin levels. J Cardiovasc Pharmacol. 1982;4:521-5. CrossrefMedlineGoogle Scholar6. PARKERFUNG JH. Transdermal nitroglycerin in angina pectoris. Am J Cardiol. 1984;54:471-6. CrossrefMedlineGoogle Scholar7. THOMPSON R. Clinical use of transdermal delivery devices with nitroglycerin [Abstract]. Circulation. 1983;68:111-407. Google Scholar8. CREANRIBEIROCREADAVIESRATCLIFFEMASERI PPFGDA. Continuous transdermal nitroglycerin administration in the treatment of chronic angina pectoris [Abstract]. Circulation. 1983;68:III-405. MedlineGoogle Scholar9. REICHEKPRIESTZIMRINCHANDLERSUTTON NCDTM. Antianginal effects of nitroglycerin patches. Am J Cardiol. 1984;54:1-7. CrossrefMedlineGoogle Scholar10. PARKERVANKOUGHNETTFUNG JKH. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy. Am J Cardiol. 1984;54:8-13. CrossrefMedlineGoogle Scholar11. NEEDLEMANJAKSCHIKJOHNSON PBE. Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther. 1973;187:324-31. MedlineGoogle Scholar12. IGNARROLIPPTONEDWARDS LHJ. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-49. MedlineGoogle Scholar13. FUNG H. Pharmacokinetics of isosorbide dinitrate during tolerance development. In; KALTENBACK M, KOBER G, eds. Nitrates and Nitrate Tolerance in Angina Pectoris. Darmstadt, West Germany: Steinkopff Verlag Darmstadt; 1983. CrossrefGoogle Scholar14. PARKERFUNGRUGGIRELLOSTONE JHDJ. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation. 1983;68:1074-80. CrossrefMedlineGoogle Scholar15. LANGEREIDFRESCHKEELARBERNHARDCOOLIDGE RMDMVG. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 1972;46:666-78. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Queen's University Kingston, Ontario Canada PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByToxicological Profile for Otto Fuels IITransdermal glyceryl trinitrate (nitroglycerin) in healthy persons: acute effects on skin temperature and hemodynamic orthostatic responseLong-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectorisNitrate: Warum und wie sie heute eingesetzt werden solltenNitrates: Why and how should they be used today?Effect of cutaneous nitroglycerin patches on coronary artery diameter: Issues concerning development of toleranceReplyPharmacologic Treatment of Angina: Nitrate ToleranceSustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failureInterdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapyAcute and sustained antianginal effects of nitroglycerin patches: Objective evaluation with training-effect-eliminated exercise performance indexEfficacy of a new transdermal nitroglycerin patch (deponit 10) for stable angina pectorisNitratesNitrate Therapy in Stable Angina PectorisEffect of Intervals between Doses on the Development of Tolerance to Isosorbide DinitrateLong-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs.Clinical Experience With a Transdermal Nitroglycerin SystemThe controversy over transdermal nitroglycerin: An updateA multicenter trial of transdermal nitroglycerin in exercise-induced angina: Individual antianginal response after repeated administrationInfluence of Transdermal Nitrates on Exercise Capacity in Patients with Stable AnginaTransdermal Nitroglycerin and Nitrate ToleranceJONATHAN ABRAMS, M.D.Update on transdermal nitroglycerin: An overview 1 April 1985Volume 102, Issue 4Page: 548-550KeywordsAnginaDrugsNitratesProphylaxis Issue Published: 1 April 1985 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
John O. Parker (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: